Skip to content

Development of self-care supportive Programe for family caregivers and stroke patients and its effects on quality of life and resilience

Development of self-care supportive Programe for family caregivers and stroke patients and its effects on quality of life and resilience; A Mixed-method study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220903055859N1
Enrollment
80
Registered
2022-09-24
Start date
2022-10-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CVA. Vascular syndromes of brain in cerebrovascular diseases

Interventions

Intervention 1: Intervention group: Intervention group: The self-care support program designed for patients and family caregivers will be implemented in four stages: ? Assessment of self-care needs in

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Family caregivers: Having at least primary education? Age above 18 years Having a family relationship with the patient (daughter, son, sister, brother, father, mother and wife) The main caregiver of the patient in the family at least 4 days a week for at least 2 months Lack of history of specific psychological illness according to self-report Patients : Having suffered a stroke for the first time The average degree of dependence based on Barthel's criteria (the patient has the ability to speak). The patient is hospitalized in the neurology department.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life of patients, quality of life of family caregivers, resilience of family caregivers. Timepoint: Upon entering the study, two months later, four months later. Method of measurement: Standard questionnaires.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactseyyed reza Bourzo

Hamedan University of Medical Sciences

borzoureza@gmail.com+98 81 3131 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026